Advertisement · 728 × 90
#
Hashtag
#biomed
Advertisement · 728 × 90

#BioMed

0 0 0 0

#BioMed

0 0 0 0
Preview
Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.

This is exciting: "People who took daraxonrasib typically lived for 13.2 months versus 6.7 months for people who took chemotherapy.... Daraxonrasib broadly targets RAS mutations, which drive tumor growth and are found in about 90% of pancreatic cancer cases." #BioMed www.cnbc.com/2026/04/13/p...

0 0 0 0

fundraising time! any useful biomedical angel investor resources or links floating around these parts? our focus is novel biomarkers of epilepsy & neurodegenation #investing #startup #startups #biomedical #neuromedical #medicine #biotech #biomed #neuroscience #epilepsy #neurodegeneration #biomarker

2 0 0 0

#askfedi any useful biomedical angel investor resources or links floating around these parts? our focus is novel biomarkers of epilepsy & neurodegenation #investing #startup #startups #biomedical #neuromedical #medicine #biotech #biomed #neuroscience #epilepsy #neurodegeneration #biomarker

0 7 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

Interesting GWAS of GLP-1 drug response and side effects. One hit was GLP1-R missense mutation. Combined genetic and non-genetic model explained 25% of variance (R^2) which is pretty good. Figure below shows binned data averaged across deciles. #BioMed

0 0 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

This is excellent from Sasha #BioMed

0 0 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

"A higher %VPA, independent of total activity volume, is inversely associated with eight major chronic diseases and all-cause mortality." #BioMed

0 0 0 0

#BioMed #Science

0 0 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

Women live longer which explains part but not all of difference #BioMed

0 0 0 0

#BioMed

0 0 0 0
Preview
AMA: AI usage among doctors doubles as confidence in technology grows Cautious optimism remains about the promise of AI.

"The 2026 results found more than four in five physicians (81 percent) use AI in their practices, more than double the 2023 rate (38 percent). Physicians are cautiously optimistic about the promise of #AI" #BioMed www.ama-assn.org/press-center...

0 0 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0

endoscopy vs blood tests 🤔

By identifying antibodies created when the immune system responds to gluten, blood testing can now help in the diagnosis of celiac disease. In certain cases, doctors may be able to diagnose the illness without a biopsy due to extremely high antibody levels.

#biomed #NHS

0 0 1 0

#BioMed

0 0 0 0

#BioMed

0 0 0 0